Aptose Biosciences Inc. Financial Summary

Complete Filing Data

Aptose Biosciences Inc. reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations of $4.10 million for FY2025.

All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Aptose Biosciences Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.

Income Statement

Annual (10-K / 20-F)

Metric \ Fiscal YearFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Net Income Loss-$25.5M-$25.4M-$51.2M-$41.8M-$65.4M-$55.2M-$26.3M-$28.9M-$11.6M
Research And Development Expense$11.3M$15.1M$33.3M$24.5M$46.0M$29.3M$16.8M$18.7M$6.3M
General And Administrative Expense$13.4M$11.2M$15.6M$14.5M$19.5M$26.5M$10.0M$10.4M$5.6M
Operating Expenses$24.7M$26.3M$52.4M$42.6M$65.4M$55.8M$26.9M$29.1M$11.8M
Nonoperating Income Expense-$745.0K$827.0K$1.1M$779.0K$93.0K$530.0K$580.0K$239.0K$183.0K
Comprehensive Income Net Of Tax-$25.4M-$51.2M-$41.8M-$65.4M-$55.3M-$26.3M-$28.9M-$11.7M
Revenue From Contract With Customer Including Assessed Tax$0.00$0.00$0.00$0.00$0.00$0.00
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax$0.00$2.0K-$2.0K$0.00-$18.0K$18.0K-$18.0K
Other Comprehensive Income Loss Net Of Tax$2.0K-$2.0K-$18.0K$18.0K-$18.0K
Cost Of Offering

Quarterly (10-Q, single quarters)

Metric \ QuarterQ3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020Q4 2019Q3 2019Q2 2019Q1 2019Q4 2018Q3 2018Q2 2018Q1 2018Q4 2017Q3 2017Q2 2017Q1 2017
Net Income Loss-$5.1M-$7.0M-$5.5M-$7.0M-$7.3M-$9.6M-$12.0M-$11.4M-$14.1M-$13.7M-$10.0M-$9.8M-$10.6M-$11.5M-$24.3M-$11.3M-$13.5M-$16.2M-$14.7M-$13.2M-$15.8M-$11.5M-$7.7M-$6.8M-$6.2M-$5.5M-$6.3M-$5.5M-$10.3M-$6.8M-$3.3M-$2.6M-$2.4M-$3.3M
Research And Development Expense$2.2M$3.3M$2.4M$4.7M$4.4M$6.4M$8.3M$10.6M$8.8M$6.6M$7.3M$7.4M$7.7M$9.8M$8.2M$7.5M$6.9M$5.9M$4.8M$3.5M$3.3M$3.6M$7.8M$3.1M
General And Administrative Expense$2.7M$3.6M$3.1M$2.3M$2.9M$3.3M$3.4M$3.9M$5.3M$3.4M$3.3M$4.1M$3.6M$3.7M$8.0M$5.8M$9.0M$5.9M$2.3M$2.9M$2.3M$2.0M$2.5M$3.7M
Operating Expenses$4.9M$6.9M$5.5M$7.0M$7.3M$9.8M$11.7M$14.5M$14.1M$10.0M$10.7M$11.5M$11.4M$13.5M$16.3M$13.3M$15.9M$11.8M$7.0M$6.3M$5.6M$5.6M$10.3M$6.8M
Nonoperating Income Expense-$210.0K-$122.0K-$82.0K$12.0K$93.0K$120.0K$234.0K$323.0K$420.0K$249.0K$108.0K$19.0K$26.0K$18.0K$25.0K$45.0K$131.0K$308.0K$183.0K$128.0K$94.0K$80.0K$67.0K$28.0K
Comprehensive Income Net Of Tax-$7.0M-$5.5M-$7.0M-$7.3M-$9.6M-$11.4M-$14.1M-$13.7M-$9.8M-$10.6M-$11.5M-$11.3M-$13.5M-$13.3M-$15.8M-$11.5M-$6.8M-$6.2M-$5.5M-$5.5M-$10.3M-$6.8M
Revenue From Contract With Customer Including Assessed Tax$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax$0.00$0.00$0.00$1.0K-$1.0K$0.00-$1.0K$4.0K$20.0K-$37.0K$0.00$0.00$0.00-$2.0K-$15.0K-$5.0K$9.0K$9.0K$9.0K-$4.0K-$2.0K
Other Comprehensive Income Loss Net Of Tax-$1.0K$4.0K$9.0K-$2.0K
Cost Of Offering$0.00$177.0K$5.0K$5.0K$0.00

Balance Sheet

Annual (10-K / 20-F)

Metric \ Fiscal YearFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations$4.1M$6.7M$9.3M$37.0M$39.1M$117.4M$79.8M$15.3M$10.6M$7.9M
Stockholders Equity-$27.2M-$4.5M-$2.9M$37.7M$74.2M$118.9M$93.9M$14.1M$10.2M$7.3M
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect-$2.6M-$2.5M-$27.7M-$2.1M-$78.3M$37.6M$64.5M$4.7M$2.7M
Operating Lease Payments$458.0K$405.0K$546.0K$555.0K$537.0K$471.0K
Interest On Lease Liabilities$34.0K$64.0K$93.0K$35.0K$43.0K$69.0K$90.0K
Assets$10.0M$10.1M$13.0M$51.0M$82.5M$126.3M$100.5M$16.9M$12.0M
Retained Earnings Accumulated Deficit-$566.4M-$541.0M-$515.5M-$464.3M-$422.5M-$357.2M-$301.9M-$275.6M-$246.8M
Property Plant And Equipment Net$4.0K$26.0K$152.0K$211.0K$323.0K$261.0K$334.0K$384.0K$142.0K
Other Assets Current$141.0K$570.0K$600.0K$257.0K$133.0K$129.0K$141.0K$101.0K$74.0K
Liabilities Current$9.3M$4.5M$15.3M$12.3M$8.2M$6.8M$5.5M$2.8M$1.8M
Liabilities And Stockholders Equity$10.0M$10.1M$13.0M$51.0M$82.5M$126.3M$100.5M$16.9M$12.0M
Interest Accrued On Investments$0.00$60.0K$18.0K-$33.0K$34.0K
Common Stock Value$459.8M$457.4M$444.8M$437.5M$437.4M$429.5M$365.5M$261.1M$231.9M
Common Stock No Par Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Cash And Cash Equivalents At Carrying Value$935.0K$6.2M$9.3M$37.0M$39.1M$117.4M$79.8M$15.3M$10.6M
Assets Noncurrent$3.6M$597.0K$1.1M$1.5M$788.0K$1.2M$1.7M$384.0K$142.0K
Assets Current$6.4M$9.5M$11.9M$49.5M$81.7M$125.1M$98.8M$16.5M$11.8M
Accumulated Other Comprehensive Income Loss Net Of Tax-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M
Accrued Liabilities Current$6.2M$2.8M$8.8M$5.1M$6.0M$4.1M$3.1M$1.5M$1.2M
Accounts Payable Current$2.9M$1.3M$3.5M$3.3M$1.7M$2.2M$2.0M$1.3M$589.0K
Operating Lease Right Of Use Asset$175.0K$571.0K$943.0K$1.3M$465.0K$925.0K$1.6M
Liabilities$37.2M$14.7M$15.9M$13.3M$8.3M$7.3M$6.6M$2.8M
Operating Lease Liability Noncurrent$0.00$193.0K$621.0K$1.0M$115.0K$535.0K$1.0M
Operating Lease Liability Current$193.0K$428.0K$394.0K$301.0K$459.0K$539.0K$521.0K
Short Term Investments$10.0M$40.0M$5.0M$17.8M$440.0K$798.0K
Operating Lease Right Of Use Asset Amortization Expense$372.0K$378.0K$408.0K$472.0K
Gain Loss On Sale Of Property Plant Equipment$0.00-$76.0K$0.00-$16.0K$0.00
Operating Lease Expense$472.0K$462.0K$461.0K
Unrealized Gain Loss On Investments
Equity-$27.2M-$4.5M-$2.9M$37.7M$74.2M$118.9M$93.9M$14.1M$10.2M$7.3M

Quarterly (10-Q, single quarters)

Metric \ QuarterQ3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021Q3 2020Q2 2020Q1 2020Q4 2019Q3 2019Q2 2019Q1 2019Q3 2018Q2 2018Q1 2018
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations$1.6M$1.3M$4.7M$8.0M$8.3M$7.3M$15.7M$8.4M$22.8M$28.0M$40.0M$37.0M$75.1M$83.3M$87.1M$99.7M$54.1M$59.8M$20.7M$26.9M$16.6M$15.1M$17.9M$15.4M
Stockholders Equity-$19.5M-$14.4M-$7.4M-$9.1M-$2.2M$137.0K$7.8M$13.8M$26.0M$46.8M$55.5M$65.3M$88.7M$98.2M$109.4M$129.2M$79.2M$87.2M$27.4M$33.8M$15.4M$13.9M$16.9M$14.5M
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect-$2.0M-$368.0K$984.0K-$1.9M$7.3M-$14.4M-$14.2M-$12.0M$3.0M-$2.1M-$8.2M-$3.7M-$30.3M$45.6M-$5.6M-$20.1M-$6.2M$10.3M$1.3M-$2.9M$2.5M$4.8M
Operating Lease Payments$116.0K$116.0K$113.0K$112.0K$119.0K$115.0K$117.0K$45.0K$128.0K$134.0K$134.0K$143.0K$139.0K$140.0K$140.0K$136.0K$134.0K$131.0K$126.0K$120.0K$99.0K
Interest On Lease Liabilities$13.0K$15.0K$18.0K$19.0K$23.0K$25.0K$25.0K$4.0K$6.0K$7.0K$10.0K$12.0K$13.0K$17.0K$19.0K$18.0K$22.0K$23.0K$24.0K
Assets$6.3M$5.6M$7.5M$10.9M$10.9M$12.8M$20.9M$26.6M$39.3M$57.0M$64.8M$72.6M$97.2M$106.2M$115.2M$135.3M$85.3M$92.6M$32.5M$38.2M$19.7M
Retained Earnings Accumulated Deficit-$558.7M-$553.6M-$546.5M-$539.4M-$532.4M-$525.2M-$503.6M-$492.1M-$478.0M-$454.3M-$444.6M-$434.0M-$398.2M-$386.9M-$373.4M-$342.4M-$329.2M-$313.4M-$294.2M-$287.4M-$281.1M
Property Plant And Equipment Net$8.0K$19.0K$23.0K$30.0K$34.0K$125.0K$170.0K$190.0K$183.0K$251.0K$281.0K$287.0K$353.0K$208.0K$243.0K$272.0K$309.0K$309.0K$361.0K$352.0K$379.0K
Other Assets Current$127.0K$116.0K$274.0K$1.4M$593.0K$674.0K$261.0K$217.0K$162.0K$346.0K$121.0K$101.0K$131.0K$141.0K$116.0K$115.0K$117.0K$117.0K$109.0K$168.0K$95.0K
Liabilities Current$7.1M$9.0M$6.3M$9.8M$12.7M$12.1M$12.4M$12.0M$12.4M$10.2M$9.3M$7.3M$8.3M$7.7M$5.4M$5.4M$5.3M$4.4M$3.9M$3.2M$3.0M
Liabilities And Stockholders Equity$6.3M$5.6M$7.5M$10.9M$10.9M$12.8M$20.9M$26.6M$39.3M$57.0M$64.8M$72.6M$97.2M$106.2M$115.2M$135.3M$85.3M$92.6M$32.5M$38.2M$19.7M
Interest Accrued On Investments$0.00$0.00$9.0K-$9.0K$44.0K$17.0K$5.0K-$78.0K-$18.0K$11.0K$3.0K-$2.0K$4.0K-$9.0K-$88.0K$60.0K$58.0K$19.0K
Common Stock Value$459.8M$459.8M$459.8M$452.3M$452.3M$450.5M$443.9M$439.1M$437.9M$437.5M$437.4M$437.4M$429.8M$429.8M$429.7M$429.5M$366.3M$366.3M$291.3M$291.2M$267.3M
Common Stock No Par Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Cash And Cash Equivalents At Carrying Value$613.0K$553.0K$4.7M$8.0M$8.3M$7.3M$15.7M$8.4M$22.8M$28.0M$40.0M$37.0M$75.1M$83.3M$87.1M$99.7M$54.1M$59.8M$20.7M$26.9M$16.6M
Assets Noncurrent$2.6M$2.3M$498.0K$694.0K$790.0K$975.0K$1.2M$1.3M$1.4M$471.0K$612.0K$729.0K$932.0K$906.0K$1.1M$1.3M$1.5M$1.6M$1.9M$1.9M$2.1M
Assets Current$3.8M$3.3M$7.0M$10.2M$10.2M$11.8M$19.7M$25.3M$37.9M$56.6M$64.2M$71.9M$96.3M$105.3M$114.1M$133.9M$83.9M$91.0M$30.6M$36.3M$17.7M
Accumulated Other Comprehensive Income Loss Net Of Tax-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M-$4.4M-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M-$4.3M
Accrued Liabilities Current$4.8M$5.4M$3.3M$7.5M$5.2M$9.3M$9.1M$8.1M$6.6M$7.5M$6.5M$5.6M$6.2M$4.3M$3.2M$3.4M$2.9M$1.9M$2.2M$1.5M$1.3M
Accounts Payable Current$1.5M$2.9M$2.4M$1.8M$7.1M$2.4M$2.8M$3.5M$5.5M$2.4M$2.4M$1.1M$1.6M$2.9M$1.6M$1.5M$1.9M$2.0M$1.2M$1.2M$1.2M
Operating Lease Right Of Use Asset$277.0K$377.0K$475.0K$664.0K$756.0K$850.0K$1.0M$1.1M$1.2M$220.0K$331.0K$442.0K$579.0K$698.0K$808.0K$1.0M$1.1M$1.3M$1.8M$1.5M$1.6M$1.7M
Liabilities$25.8M$20.0M$14.9M$20.1M$13.1M$12.7M$13.1M$12.8M$13.3M$10.2M$9.3M$7.3M$8.5M$8.0M$5.8M$6.1M$6.1M$5.3M$5.0M$4.4M$4.3M
Operating Lease Liability Noncurrent$0.00$0.00$80.0K$305.0K$414.0K$520.0K$720.0K$817.0K$918.0K$1.0K$3.0K$10.0K$218.0K$321.0K$420.0K$658.0K$776.0K$894.0K$1.1M$1.2M$1.3M
Operating Lease Liability Current$305.0K$413.0K$441.0K$416.0K$404.0K$399.0K$390.0K$387.0K$306.0K$270.0K$398.0K$519.0K$482.0K$508.0K$530.0K$537.0K$528.0K$525.0K$513.0K$493.0K$485.0K
Short Term Investments$2.0M$2.0M$14.9M$13.0M$27.4M$22.4M$32.5M$20.0M$20.0M$25.0M$33.0M$28.6M$30.2M$9.5M$8.5M$449.0K
Operating Lease Right Of Use Asset Amortization Expense$96.0K$92.0K$94.0K$93.0K$91.0K$92.0K$103.0K$111.0K$111.0K$114.0K$119.0K$117.0K$117.0K
Gain Loss On Sale Of Property Plant Equipment$0.00$0.00-$66.0K-$10.0K$0.00$0.00$0.00$0.00$0.00-$4.0K$0.00$0.00$0.00
Operating Lease Expense$119.0K$117.0K$117.0K$116.0K$115.0K$115.0K$115.0K$107.0K$124.0K
Unrealized Gain Loss On Investments$2.0K$0.00-$1.0K$1.0K$1.0K-$2.0K$4.0K-$7.0K
Equity-$19.5M-$14.4M-$7.4M-$9.1M-$2.2M$137.0K$7.8M$13.8M$26.0M$46.8M$55.5M$65.3M$88.7M$98.2M$109.4M$129.2M$79.2M$87.2M$27.4M$33.8M$15.4M$13.9M$16.9M$14.5M

Cash Flow Statement

Annual (10-K / 20-F)

Metric \ Fiscal YearFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Share Based Compensation$477.0K$1.1M$3.7M$5.2M$12.9M$21.4M$2.3M$4.3M$817.0K
Net Cash Provided By Used In Operating Activities-$22.0M-$36.0M-$44.6M-$32.3M-$43.3M-$33.9M-$21.6M-$23.2M-$10.2M
Net Cash Provided By Used In Financing Activities$19.4M$33.4M$6.9M$116.0K$226.0K$58.8M$103.4M$27.9M$13.7M
Increase Decrease In Prepaid Expense-$44.0K$211.0K-$261.0K-$173.0K-$78.0K$1.5M$379.0K$324.0K-$70.0K
Increase Decrease In Accrued Liabilities$3.4M-$6.1M$3.7M-$3.9M$1.9M$1.0M$1.7M$298.0K-$142.0K
Net Cash Provided By Used In Investing Activities$0.00$18.0K$10.0M$30.1M-$35.2M$12.6M-$17.4M$12.0K-$811.0K
Increase Decrease In Other Operating Assets$3.0M-$30.0K$343.0K$124.0K$4.0K-$12.0K$40.0K$27.0K-$27.0K
Depreciation Depletion And Amortization$88.0K$120.0K$150.0K$152.0K$152.0K$87.0K$84.0K
Payments For Proceeds From Investments-$10.0M-$30.1M$35.0M-$12.7M$17.3M-$341.0K$798.0K
Increase Decrease In Accounts Payable$4.6M-$472.0K$211.0K$645.0K$726.0K$589.0K
Payments To Acquire Property Plant And Equipment$0.00$5.0K$29.0K$24.0K$212.0K$79.0K$102.0K$329.0K$13.0K
Proceeds From Stock Options Exercised$0.00$15.0K$190.0K$573.0K$718.0K$240.0K
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations$0.00$2.0K-$4.0K$7.0K
Effect Of Exchange Rate On Cash And Cash Equivalents$7.0K$7.0K$23.0K-$8.0K$7.0K
Payments Of Stock Issuance Costs$0.00$168.0K$437.0K$15.0K$307.00
Increase Decrease In Accounts Payable Related Parties$0.00-$2.6M-$430.0K$3.0M
Proceeds From Stock Plans
Increase Decrease In Accounts Payable Excluding Related Parties-$2.2M$150.0K$4.6M

Quarterly (10-Q, single quarters)

Metric \ QuarterQ1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021Q3 2020Q2 2020Q1 2020Q3 2019Q2 2019Q1 2019Q3 2018Q2 2018Q1 2018
Share Based Compensation$326.0K-$13.0K$207.0K$809.0K$599.0K$769.0K$1.9M$1.1M$779.0K$2.5M$1.8M$2.2M$6.6M$4.9M$7.7M$4.4M$504.0K$568.0K$662.0K$952.0K$515.0K$2.2M
Net Cash Provided By Used In Operating Activities-$2.8M-$10.4M-$5.8M-$11.8M-$10.5M-$13.5M-$11.3M-$7.0M-$7.0M-$9.6M-$8.1M-$8.8M-$10.4M-$8.3M-$7.2M-$8.1M-$5.2M-$5.3M-$4.9M-$4.5M-$9.2M-$4.1M
Net Cash Provided By Used In Financing Activities$829.0K$10.0M$4.8M$11.8M$4.9M$1.1M$50.0K$21.0K$29.0K$15.0K$0.00$85.0K$75.0K$58.3M$46.0K$436.0K$17.0K$23.6M$6.2M$1.6M$11.6M$8.9M
Increase Decrease In Prepaid Expense-$301.0K-$324.0K-$560.0K-$246.0K-$29.0K-$311.0K-$256.0K-$825.0K-$599.0K$214.0K-$788.0K-$124.0K-$608.0K$83.0K$137.0K-$139.0K-$437.0K$183.0K-$107.0K-$68.0K$139.0K-$73.0K
Increase Decrease In Accrued Liabilities$551.0K$2.3M-$4.1M$490.0K$1.0M$1.5M$937.0K$1.0M$875.0K-$370.0K$1.9M$1.1M-$871.0K$486.0K$1.0M-$1.2M$735.0K$164.0K-$74.0K-$73.0K-$588.0K$667.0K
Net Cash Provided By Used In Investing Activities$0.00$0.00$2.0M-$2.0M$13.0M-$2.0M-$3.0M-$5.1M$10.1M$7.5M-$185.0K$5.0M-$20.0M-$4.4M$1.5M-$12.4M-$1.0M-$8.0M-$24.0K-$28.0K$150.0K-$24.0K
Increase Decrease In Other Operating Assets-$296.0K$768.0K-$81.0K$74.0K$44.0K$55.0K-$95.0K$225.0K$20.0K$32.0K-$10.0K$25.0K-$13.0K-$2.0K$0.00-$24.0K-$59.0K$73.0K-$6.0K-$66.0K$108.0K$23.0K
Depreciation Depletion And Amortization$4.0K$8.0K$16.0K$20.0K$22.0K$28.0K$30.0K$30.0K$32.0K$36.0K$35.0K$35.0K$37.0K$37.0K$41.0K$33.0K$53.0K$29.0K$29.0K$19.0K$16.0K
Payments For Proceeds From Investments$0.00$0.00-$2.0M$2.0M-$13.0M$1.9M$3.0M$5.1M-$10.1M$7.5M$4.0K-$5.0M$20.0M$4.4M-$1.5M$12.4M$1.0M$8.0M-$250.0K
Increase Decrease In Accounts Payable-$690.0K-$2.0M-$807.0K$23.0K$1.2M-$555.0K-$1.3M$1.3M-$563.0K-$374.0K-$114.0K$57.0K-$66.0K$70.0K-$145.0K$40.0K$784.0K-$227.0K
Payments To Acquire Property Plant And Equipment$29.0K$0.00$24.0K$0.00$181.0K$0.00$17.0K$0.00$37.0K$16.0K$42.0K$26.0K$24.0K$28.0K$100.0K$24.0K
Proceeds From Stock Options Exercised$0.00$0.00$0.00$0.00$0.00$15.0K$0.00$85.0K$75.0K$49.0K$46.0K$436.0K$17.0K$19.0K$36.0K$183.0K
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations$2.0K$0.00-$1.0K$1.0K$1.0K-$3.0K$4.0K-$7.0K-$5.0K$2.0K-$4.0K$1.0K$3.0K
Effect Of Exchange Rate On Cash And Cash Equivalents-$4.0K$1.0K$3.0K$0.00-$3.0K$14.0K-$3.0K-$1.0K$2.0K
Payments Of Stock Issuance Costs$142.0K$7.0K$2.0K$5.0K
Increase Decrease In Accounts Payable Related Parties$0.00$0.00$0.00-$2.6M$0.00-$1.4M$0.00
Proceeds From Stock Plans$8.0K$0.00$18.0K$13.0K$0.00$16.0K$0.00$0.00
Increase Decrease In Accounts Payable Excluding Related Parties$1.1M-$5.3M$4.7M-$1.1M-$690.0K-$629.0K-$807.0K

Per-Share & Share Counts

Annual (10-K / 20-F)

Metric \ Fiscal YearFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Diluted EPS *-$10.41-$36.38-$227.43-$6.80-$0.73-$0.67-$0.52-$0.86-$0.52
Common Stock Shares Outstanding2.6M2.0M264.7K6.2M92.2M88.9M76.1M38.2M27.5M
Common Stock Shares Issued2.6M2.0M264.7K6.2M92.2M88.9M76.1M38.2M27.5M
Earnings Per Share Basic$-10.41$-36.38$-227.43$-6.80$-0.73
Weighted Average Number Of Share Outstanding Basic And Diluted89.1M81.8M50.2M33.4M22.3M
Weighted Average Number Of Shares Outstanding Basic2.4M699.0K225.2K6.2M89.1K
Weighted Average Number Of Diluted Shares Outstanding2.4M699.0K225.2K6.2M89.1K

Quarterly (10-Q, single quarters)

Metric \ QuarterQ3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020Q4 2019Q3 2019Q2 2019Q1 2019Q4 2018Q3 2018Q2 2018Q1 2018Q4 2017Q3 2017Q2 2017Q1 2017
Diluted EPS *-$2.01-$2.76-$2.61-$11.33-$12.99-$22.02-$1.57-$1.76-$2.27-$2.22-$1.67-$1.66-$1.66-$1.81-$0.27-$0.13-$0.15-$0.18-$0.17-$0.15-$0.21-$0.15-$0.13-$0.12-$0.13-$0.14-$0.17-$0.16-$0.30-$0.23-$0.12-$0.11-$0.11-$0.19
Common Stock Shares Outstanding2.6M2.6M2.6M19.5M18.1M15.7M7.5M6.4M93.0M92.3M92.3M92.2M88.9M88.9M88.9M88.9M76.3M76.3M55.5M55.4M41.50B
Common Stock Shares Issued2.6M2.6M2.6M19.5M18.1M15.7M7.5M6.4M93.0M92.3M92.3M92.2M88.9M88.9M88.9M88.9M76.3M76.3M55.5M55.4M41.50B
Earnings Per Share Basic$-2.01$-2.76$-2.61$-11.33$-12.99$-22.02$-1.57$-1.76$-2.27$-2.22$-1.67$-1.66$-1.66$-1.81$-0.27$-0.13$-0.15$-0.18
Weighted Average Number Of Share Outstanding Basic And Diluted88.9M88.9M88.9M85.9M76.3M76.2M55.5M46.5M39.8M34.6M34.0M29.0M
Weighted Average Number Of Shares Outstanding Basic2.6M2.6M2.1M613.6K558.5K437.8K6.5M6.2M6.2M6.2M6.2M92.2M88.9M88.9M
Weighted Average Number Of Diluted Shares Outstanding2.6M2.6M2.1M613.6K558.5K437.8K6.5M6.2M6.2M6.2M6.2M92.2M

Other Metrics

Annual (10-K / 20-F)

Metric \ Fiscal YearFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Investment Income Interest$105.0K$357.0K$1.2M$788.0K$94.0K$522.0K$574.0K$283.0K$68.0K
Foreign Currency Transaction Gain Loss Realized-$7.0K-$9.0K-$2.0K-$9.0K-$1.0K$8.0K$6.0K-$44.0K$115.0K
Foreign Currency Transaction Gain Loss Before Tax$0.00-$4.0K$7.0K$8.0K$23.0K-$25.0K$25.0K
Prepaid Expense Current$2.2M$2.3M$2.0M$2.3M$2.5M$2.6M$1.0M$646.0K$322.0K
Additional Paid In Capital$83.8M$83.3M$72.1M$68.9M$63.7M$50.9M$34.6M$33.0M$29.4M
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value$477.0K$1.1M$3.7M$5.2M$12.9M$21.4M$2.3M$4.3M$817.0K
Stock Issued During Period Shares Stock Options Exercised0.001.0K82.0K235.0K235.0K114.0K
Stock Issued During Period Value Stock Options Exercised$15.0K$190.0K$573.0K$718.0K$240.0K
Stock Issued During Period Shares Employee Stock Purchase Plans922.00195.00724.000.00
Stock Issued During Period Value Employee Stock Purchase Plan$1.0K$26.0K$29.0K$7.0K
Issuance Of Stock And Warrants For Services Or Claims$0.00$7.5M$0.00$360.0K$600.0K
Stock Issued During Period Value New Issues$324.0K
Shares Issuances To Hanmi

Quarterly (10-Q, single quarters)

Metric \ QuarterQ3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021Q3 2020Q2 2020Q1 2020Q3 2019Q2 2019Q1 2019Q3 2018Q2 2018Q1 2018
Investment Income Interest$12.0K$93.0K$121.0K$232.0K$326.0K$422.0K$254.0K$111.0K$22.0K$22.0K$23.0K$27.0K$46.0K$116.0K$323.0K$187.0K$128.0K$92.0K$80.0K$74.0K$44.0K
Foreign Currency Transaction Gain Loss Realized$2.0K-$12.0K$2.0K$0.00$0.00-$1.0K$2.0K-$3.0K-$2.0K-$5.0K-$3.0K-$3.0K$4.0K-$5.0K-$2.0K-$1.0K$15.0K-$15.0K-$4.0K$2.0K-$7.0K-$16.0K
Foreign Currency Transaction Gain Loss Before Tax-$2.0K$4.0K-$7.0K-$5.0K$2.0K-$4.0K$2.0K$3.0K$0.00-$3.0K$15.0K-$5.0K$1.0K$2.0K$19.0K$4.0K-$26.0K
Prepaid Expense Current$2.0M$1.9M$2.0M$912.0K$1.2M$1.8M$1.7M$1.7M$2.0M$838.0K$1.7M$2.3M$1.0M$1.8M$1.9M$1.1M$1.0M$886.0K$285.0K$722.0K$539.0K
Additional Paid In Capital$83.8M$83.7M$83.7M$82.3M$82.3M$79.1M$71.7M$71.1M$70.4M$68.0M$67.0M$66.2M$61.4M$59.6M$57.5M$46.5M$46.4M$38.7M$34.6M$34.2M$33.6M
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value$326.0K$809.0K$1.9M$2.5M$6.6M$4.4M$662.0K$2.2M
Stock Issued During Period Shares Stock Options Exercised0.0014.0K39.0K162.0K
Stock Issued During Period Value Stock Options Exercised$15.0K$75.0K$436.0K
Stock Issued During Period Shares Employee Stock Purchase Plans338.00363.001.4K0.00
Stock Issued During Period Value Employee Stock Purchase Plan$1.0K$18.0K$16.0K
Issuance Of Stock And Warrants For Services Or Claims$360.0K$600.0K
Stock Issued During Period Value New Issues$23.0K$34.0K
Shares Issuances To Hanmi0.000.003.7M3.0M0.000.000.00

Most recent annual filing with the SEC: March 31, 2026

Data sourced from SEC EDGAR public filings as of August 5, 2026.